$LSEB
LSEB Creative Corp.

2023 Q3 Form 10-Q Financial Statement

#000119983523000451 Filed on August 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $59.50K $31.13K $32.95K
YoY Change 64.46% -9.29%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $70.00 $80.00 $80.00
YoY Change -30.0% -20.0%
% of Gross Profit
Operating Expenses $59.57K $31.21K $33.04K
YoY Change 64.22% -9.35%
Operating Profit -$59.57K -$31.21K
YoY Change 64.22% -9.35%
Interest Expense -$1.770K -$80.00 $430.00
YoY Change -32.7% -96.69%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$61.34K -$31.29K -$32.61K
YoY Change 57.68% -15.07%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$61.34K -$31.29K -$32.61K
YoY Change 57.68% -15.07%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 14.31M shares 13.47M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.23K $29.40K $2.710K
YoY Change -70.04% -39.93%
Cash & Equivalents $13.23K $29.40K $2.710K
Short-Term Investments
Other Short-Term Assets $46.69K $143.4K $145.1K
YoY Change 438.52% 8750.62%
Inventory $105.4K $3.526K $3.526K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $165.4K $176.3K $151.3K
YoY Change 213.01% 248.66% 146.01%
LONG-TERM ASSETS
Property, Plant & Equipment $861.00 $931.00 $1.007K
YoY Change -26.85% -26.81% -26.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $861.00 $931.00 $1.007K
YoY Change -26.85% -26.81% -26.76%
TOTAL ASSETS
Total Short-Term Assets $165.4K $176.3K $151.3K
Total Long-Term Assets $861.00 $931.00 $1.007K
Total Assets $166.2K $177.2K $152.3K
YoY Change 207.78% 241.9% 142.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.280K $1.461K $5.095K
YoY Change -89.82% -85.65% -62.86%
Accrued Expenses $2.236K $10.13K $8.109K
YoY Change -63.3% 4.67%
Deferred Revenue
YoY Change
Short-Term Debt $64.61K $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $68.13K $77.50K $69.97K
YoY Change 208.11% 268.34% 359.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $68.13K $77.50K $69.97K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $68.13K $77.50K $69.97K
YoY Change 208.14% 268.35%
SHAREHOLDERS EQUITY
Retained Earnings -$483.6K -$422.3K -$391.0K
YoY Change 50.02% 48.97% 58.54%
Common Stock $1.465K $1.406K $1.357K
YoY Change 18.34% 15.06% 12.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $98.10K $99.74K $82.33K
YoY Change
Total Liabilities & Shareholders Equity $166.2K $177.2K $152.3K
YoY Change 207.78% 241.9% 142.23%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$61.34K -$31.29K -$32.61K
YoY Change 57.68% -15.07%
Depreciation, Depletion And Amortization $70.00 $80.00 $80.00
YoY Change -30.0% -20.0%
Cash From Operating Activities -$70.08K -$26.65K -$141.0K
YoY Change 55.35% -5.55%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $44.20K
YoY Change 121.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 53.90K $53.34K 81.83K
YoY Change 33.61% 171.25%
NET CHANGE
Cash From Operating Activities -70.08K -$26.65K -141.0K
Cash From Investing Activities 0.000
Cash From Financing Activities 53.90K $53.34K 81.83K
Net Change In Cash -16.18K $26.69K -59.14K
YoY Change 239.2% -412.0%
FREE CASH FLOW
Cash From Operating Activities -$70.08K -$26.65K -$141.0K
Capital Expenditures $0.00
Free Cash Flow -$141.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001888740
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023Q2 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
usd
CY2023 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
usd
CY2023Q2 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
usd
CY2023 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
usd
CY2023 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
usd
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
333-260873
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
LSEB CREATIVE CORP.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-4415385
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
30 N. Gould St. #4000
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Sheridan,
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
WY
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
82801
CY2023Q2 dei City Area Code
CityAreaCode
800
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
701-8561
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14308000 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29395 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2710 usd
CY2023Q2 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
141362 usd
CY2023Q1 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
141362 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
3526 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
3526 usd
CY2023Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2019 usd
CY2023Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
3695 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
176302 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
151293 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
931 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1007 usd
CY2023Q2 us-gaap Assets
Assets
177233 usd
CY2023Q1 us-gaap Assets
Assets
152300 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1461 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5095 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10132 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8109 usd
CY2023Q2 lseb Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
65902 usd
CY2023Q1 lseb Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
56767 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
77495 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
69971 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14056000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14056000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13569000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13569000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1406 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1357 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
520604 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
471953 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-422272 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-390981 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
99738 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
82329 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
177233 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
152300 usd
CY2023Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
15896 usd
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1933 usd
CY2023Q2 lseb Consulting Expenses
ConsultingExpenses
4533 usd
CY2022Q2 lseb Consulting Expenses
ConsultingExpenses
14158 usd
CY2023Q2 us-gaap Legal Fees
LegalFees
4292 usd
CY2022Q2 us-gaap Legal Fees
LegalFees
12848 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6410 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5383 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
76 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
103 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
31207 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
34425 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-31207 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-34425 usd
CY2023Q2 lseb Exchange Gainloss
ExchangeGainloss
84 usd
CY2022Q2 lseb Exchange Gainloss
ExchangeGainloss
2417 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31291 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36842 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-31291 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-36842 usd
CY2023Q2 lseb Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.0024
CY2022Q2 lseb Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.0031
CY2023Q2 lseb Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
13004877 shares
CY2022Q2 lseb Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
11836685 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
82329 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4500 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
44200 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-31291 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
99738 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
47640 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-36842 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
30798 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-31291 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-36842 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
76 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
103 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
4500 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
1676 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
2381 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2023 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9680 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3634 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3538 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26650 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28216 usd
CY2023Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
10925 usd
CY2022Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
-209 usd
CY2023Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1790 usd
CY2022Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
128 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
44200 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
53335 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19663 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
26685 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8553 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2710 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57497 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29395 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48944 usd
CY2023Q2 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80A_eus-gaap--NatureOfOperations_zbg1yy5o6E1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.3in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_822_zZ5S0LU5EoUc">NATURE OF OPERATIONS</span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">LSEB Creative Corp. was incorporated as “Profit Corporation” on April 3<sup>rd</sup>, 2019 under Wyoming State regulations with registered office at 1920 Thomes Ave Ste 610, Cheyenne, WY.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">LSEB Creative Corp. is a specialty retailer that offers men and women elevated swimwear designs, constructed with the highest quality materials and techniques. Our product concept focuses on coordinating items within the men’s and women’s sub-categories, which allows customers the ability to coordinate with their partner. It’s this concept, along with our noteworthy fabrics, construction techniques, and “ready-to-wear” inspired designs that will allow LSEB to capture a new space within the market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Its aim is to become a leading retailer in the global luxury fashion industry. The corporation is currently involved in concept, design, manufacturing, and distribution of its products with emphasis on its swim wear category.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company operates under the web-site address <span style="text-decoration: underline">lsebcreative.com</span> and its e-commerce platform laurenbentleyswim.com which is complete however due to Covid, the Company was waiting for the appropriate time to launch and make the site live. The Company expects to launch the brand with its first collection in the summer 2023.</span></p>
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29395 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2710 usd
CY2023Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_846_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zcX0VPxsWPhc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i><span style="text-decoration: underline"><span id="xdx_86C_zdB7ijeVNPC1">Reclassification</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Certain prior year amounts have been reclassified for comparative purposes to conform to the current year financial statement presentation. These reclassifications had no effect on previous reported results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
15896 usd
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1933 usd
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zQrUq2Z96VJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i><span style="text-decoration: underline"><span id="xdx_861_zZzDBNixDA6">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The preparation of audited financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Areas involving significant estimates and assumptions include deferred income tax assets and related valuation allowance, valuation of convertible notes, warrants and accruals. Actual results could differ from those estimates. These estimates are reviewed periodically, and, as adjustments become necessary, they are reported in earnings in the period in which they become known.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Accumulated Depreciation Depletion And Amortization Reclassifications From Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationReclassificationsFromPropertyPlantAndEquipment1
368 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1813 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1737 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
931 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1007 usd
CY2023Q2 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<p id="xdx_84C_eus-gaap--RevenueRecognitionDeferredRevenue_zmPidNESWkU1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i><span style="text-decoration: underline"><span id="xdx_864_zJP2u8EV9bP1">Revenue Recognition</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company recognizes revenue in accordance with ASC-606 by,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.3in"></td><td style="width: 0.3in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying the contract(s) with a customer,</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.3in"></td><td style="width: 0.3in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying the performance obligations in the contract,</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.3in"></td><td style="width: 0.3in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining the transaction price,</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.3in"></td><td style="width: 0.3in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocating the transaction price to the performance obligations in the contract and</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.3in"></td><td style="width: 0.3in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognizing revenue when the performance obligation is satisfied.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Accordingly, the Company recognizes revenue when performance obligations under the terms of the contracts are satisfied. Our performance obligations primarily consist of delivering products to our customers. Control is transferred upon providing the products to customers upon shipment of our products to the consumers from our ecommerce sites. Once control is transferred to the customer, we have completed our performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
141362 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2744 usd
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2744 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2744 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2744 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1737 usd
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1369 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Reclassifications From Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationReclassificationsFromPropertyPlantAndEquipment1
76 usd
CY2023Q2 lseb Disclosure Advances To A Related Party Details Abstract
DisclosureAdvancesToARelatedPartyDetailsAbstract
<table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--DisclosureAdvancesToARelatedPartyDetailsAbstract_zDS6BovkCfF1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ADVANCES TO A RELATED PARTY (Details)"> <tr style="vertical-align: bottom"> <td style="border-top: Black 1pt solid; white-space: nowrap; text-align: center"> </td><td style="border-top: Black 1pt solid; font-weight: bold"> </td> <td colspan="2" id="xdx_491_20230630_zYtesyVxJ2mg" style="border-top: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">June 30,</td><td style="border-top: Black 1pt solid; font-weight: bold"> </td><td style="border-top: Black 1pt solid; font-weight: bold"> </td> <td colspan="2" id="xdx_497_20230331_zX7QGv0wWGoj" style="border-top: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">March 31,</td><td style="border-top: Black 1pt solid; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"> </td><td style="border-bottom: Black 1pt solid"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">$</td><td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">$</td><td style="border-bottom: Black 1pt solid"> </td></tr> <tr id="xdx_40B_ecustom--AccountsPayableRelatedPartiesCurrent1_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JordanStarkmanMember_zXjgm2uXtlil" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left; text-indent: 0pt; padding-left: 0pt">Jordan Starkman</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right">64,832</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right">55,034</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--AccountsPayableRelatedPartiesCurrent1_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LaurenBentleyMember_zUmAr77ikjmd" style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left; text-indent: 0pt; padding-left: 0pt">Lauren Bentley</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,070</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,733</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--AccountsPayableRelatedPartiesCurrent1_iI_zQTpcd0SblL9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-indent: 0pt; padding-left: 0pt">TOTAL</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">65,902</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,767</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table>
CY2023Q2 lseb Accounts Payable Related Parties Current1
AccountsPayableRelatedPartiesCurrent1
65902 usd
CY2023Q1 lseb Accounts Payable Related Parties Current1
AccountsPayableRelatedPartiesCurrent1
56767 usd
CY2023Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
2991 usd
CY2022Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
19878 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14056000 shares
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
37000 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3700 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
45000 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4500 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
150000 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
100000 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
50000 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
60000 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4500 usd

Files In Submission

Name View Source Status
0001199835-23-000451-index-headers.html Edgar Link pending
0001199835-23-000451-index.html Edgar Link pending
0001199835-23-000451.txt Edgar Link pending
0001199835-23-000451-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lseb-10q.htm Edgar Link pending
lseb-20230630.xsd Edgar Link pending
lseb-ex31_1.htm Edgar Link pending
lseb-ex31_2.htm Edgar Link pending
lseb-ex32_1.htm Edgar Link pending
lseb-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lseb-20230630_cal.xml Edgar Link unprocessable
lseb-20230630_def.xml Edgar Link unprocessable
lseb-20230630_lab.xml Edgar Link unprocessable
lseb-20230630_pre.xml Edgar Link unprocessable
lseb-10q_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending